BioCentury
ARTICLE | Clinical News

Oral Relistor methylnaltrexone regulatory update

September 14, 2015 7:00 AM UTC

FDA accepted for review an NDA from Valeant for oral Relistor methylnaltrexone to treat opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain. The PDUFA date is April 19, 20...